Adamis Pharmaceuticals Corporation Issues Nationwide

SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) is voluntarily recalling certain lots of SYMJEPI...

Related Keywords

United States ,Craig Stenland ,Robert Uhl ,Drug Administration ,Adamis Pharmaceuticals ,Adamis Pharmaceuticals Corporation Nasdaq ,Pharmaceuticals Corporation ,Pre Filled Single Dose Syringes ,Watch Adverse Event Reporting ,Nasdaq Admp ,Adamis Pharmaceuticals Corporation ,Admp ,Symjepi ,Llergic Reaction ,Anaphylaxis ,